Global Oncology Injection Drug Sales Market Report 2021

1 Oncology Injection Drug Market Overview

• 1.1 Oncology Injection Drug Product Scope
• 1.2 Oncology Injection Drug Segment by Type
  • 1.2.1 Global Oncology Injection Drug Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Organs
  • 1.2.3 Central Nervous System
  • 1.2.4 Circulatory/Musculoskeletal System
  • 1.2.5 Other
• 1.3 Oncology Injection Drug Segment by Application
  • 1.3.1 Global Oncology Injection Drug Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Lymphoma
  • 1.3.3 Myeloma
  • 1.3.4 Prostate Cancer
  • 1.3.5 Other
• 1.4 Oncology Injection Drug Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Oncology Injection Drug Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Oncology Injection Drug Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Oncology Injection Drug Price Trends (2016-2027)

2 Oncology Injection Drug Estimates and Forecasts by Region

• 2.1 Global Oncology Injection Drug Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Oncology Injection Drug Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Oncology Injection Drug Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Oncology Injection Drug Revenue Market Share by Region (2016-2021)
• 2.3 Global Oncology Injection Drug Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Oncology Injection Drug Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Oncology Injection Drug Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Oncology Injection Drug Estimates and Projections (2016-2027)
  • 2.4.2 Europe Oncology Injection Drug Estimates and Projections (2016-2027)
  • 2.4.3 China Oncology Injection Drug Estimates and Projections (2016-2027)
  • 2.4.4 Japan Oncology Injection Drug Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Oncology Injection Drug Estimates and Projections (2016-2027)
  • 2.4.6 India Oncology Injection Drug Estimates and Projections (2016-2027)

3 Global Oncology Injection Drug Competition Landscape by Players

• 3.1 Global Top Oncology Injection Drug Players by Sales (2016-2021)
• 3.2 Global Top Oncology Injection Drug Players by Revenue (2016-2021)
• 3.3 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2020)
• 3.4 Global Oncology Injection Drug Average Price by Company (2016-2021)
• 3.5 Manufacturers Oncology Injection Drug Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Oncology Injection Drug Market Size by Type

• 4.1 Global Oncology Injection Drug Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Oncology Injection Drug Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Oncology Injection Drug Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Oncology Injection Drug Price by Type (2016-2021)
• 4.2 Global Oncology Injection Drug Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Oncology Injection Drug Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Oncology Injection Drug Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Oncology Injection Drug Price Forecast by Type (2022-2027)

5 Global Oncology Injection Drug Market Size by Application

• 5.1 Global Oncology Injection Drug Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Oncology Injection Drug Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Oncology Injection Drug Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Oncology Injection Drug Price by Application (2016-2021)
• 5.2 Global Oncology Injection Drug Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Oncology Injection Drug Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Oncology Injection Drug Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Oncology Injection Drug Price Forecast by Application (2022-2027)

6 North America Oncology Injection Drug Market Facts & Figures

• 6.1 North America Oncology Injection Drug Sales by Company
  • 6.1.1 North America Oncology Injection Drug Sales by Company (2016-2021)
  • 6.1.2 North America Oncology Injection Drug Revenue by Company (2016-2021)
• 6.2 North America Oncology Injection Drug Sales Breakdown by Type
  • 6.2.1 North America Oncology Injection Drug Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Oncology Injection Drug Sales Breakdown by Type (2022-2027)
• 6.3 North America Oncology Injection Drug Sales Breakdown by Application
  • 6.3.1 North America Oncology Injection Drug Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Oncology Injection Drug Sales Breakdown by Application (2022-2027)

7 Europe Oncology Injection Drug Market Facts & Figures

• 7.1 Europe Oncology Injection Drug Sales by Company
  • 7.1.1 Europe Oncology Injection Drug Sales by Company (2016-2021)
  • 7.1.2 Europe Oncology Injection Drug Revenue by Company (2016-2021)
• 7.2 Europe Oncology Injection Drug Sales Breakdown by Type
  • 7.2.1 Europe Oncology Injection Drug Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Oncology Injection Drug Sales Breakdown by Type (2022-2027)
• 7.3 Europe Oncology Injection Drug Sales Breakdown by Application
  • 7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)

8 China Oncology Injection Drug Market Facts & Figures

• 8.1 China Oncology Injection Drug Sales by Company
  • 8.1.1 China Oncology Injection Drug Sales by Company (2016-2021)
  • 8.1.2 China Oncology Injection Drug Revenue by Company (2016-2021)
• 8.2 China Oncology Injection Drug Sales Breakdown by Type
  • 8.2.1 China Oncology Injection Drug Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Oncology Injection Drug Sales Breakdown by Type (2022-2027)
• 8.3 China Oncology Injection Drug Sales Breakdown by Application
  • 8.3.1 China 164 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 164 Sales Breakdown by Application (2022-2027)

9 Japan Oncology Injection Drug Market Facts & Figures

• 9.1 Japan Oncology Injection Drug Sales by Company
  • 9.1.1 Japan Oncology Injection Drug Sales by Company (2016-2021)
  • 9.1.2 Japan Oncology Injection Drug Revenue by Company (2016-2021)
• 9.2 Japan Oncology Injection Drug Sales Breakdown by Type
  • 9.2.1 Japan Oncology Injection Drug Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Oncology Injection Drug Sales Breakdown by Type (2022-2027)
• 9.3 Japan Oncology Injection Drug Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Oncology Injection Drug Market Facts & Figures

• 10.1 Southeast Asia Oncology Injection Drug Sales by Company
  • 10.1.1 Southeast Asia Oncology Injection Drug Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Oncology Injection Drug Revenue by Company (2016-2021)
• 10.2 Southeast Asia Oncology Injection Drug Sales Breakdown by Type
  • 10.2.1 Southeast Asia Oncology Injection Drug Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Oncology Injection Drug Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Oncology Injection Drug Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Oncology Injection Drug Market Facts & Figures

• 11.1 India Oncology Injection Drug Sales by Company
  • 11.1.1 India Oncology Injection Drug Sales by Company (2016-2021)
  • 11.1.2 India Oncology Injection Drug Revenue by Company (2016-2021)
• 11.2 India Oncology Injection Drug Sales Breakdown by Type
  • 11.2.1 India Oncology Injection Drug Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Oncology Injection Drug Sales Breakdown by Type (2022-2027)
• 11.3 India Oncology Injection Drug Sales Breakdown by Application
  • 11.3.1 India Oncology Injection Drug Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Oncology Injection Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Oncology Injection Drug Business

• 12.1 Taj Oncology
  • 12.1.1 Taj Oncology Corporation Information
  • 12.1.2 Taj Oncology Business Overview
  • 12.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Taj Oncology Oncology Injection Drug Products Offered
  • 12.1.5 Taj Oncology Recent Development
• 12.2 S.G. Biopharm
  • 12.2.1 S.G. Biopharm Corporation Information
  • 12.2.2 S.G. Biopharm Business Overview
  • 12.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
  • 12.2.5 S.G. Biopharm Recent Development
• 12.3 AdvaCare
  • 12.3.1 AdvaCare Corporation Information
  • 12.3.2 AdvaCare Business Overview
  • 12.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 AdvaCare Oncology Injection Drug Products Offered
  • 12.3.5 AdvaCare Recent Development
• 12.4 Merrimack
  • 12.4.1 Merrimack Corporation Information
  • 12.4.2 Merrimack Business Overview
  • 12.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Merrimack Oncology Injection Drug Products Offered
  • 12.4.5 Merrimack Recent Development
• 12.5 Celgene
  • 12.5.1 Celgene Corporation Information
  • 12.5.2 Celgene Business Overview
  • 12.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Celgene Oncology Injection Drug Products Offered
  • 12.5.5 Celgene Recent Development
• 12.6 Allos Therapeutics
  • 12.6.1 Allos Therapeutics Corporation Information
  • 12.6.2 Allos Therapeutics Business Overview
  • 12.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
  • 12.6.5 Allos Therapeutics Recent Development
• 12.7 Ferring Pharmaceuticals
  • 12.7.1 Ferring Pharmaceuticals Corporation Information
  • 12.7.2 Ferring Pharmaceuticals Business Overview
  • 12.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
  • 12.7.5 Ferring Pharmaceuticals Recent Development
• 12.8 Genzyme
  • 12.8.1 Genzyme Corporation Information
  • 12.8.2 Genzyme Business Overview
  • 12.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Genzyme Oncology Injection Drug Products Offered
  • 12.8.5 Genzyme Recent Development
• 12.9 Eli Lilly
  • 12.9.1 Eli Lilly Corporation Information
  • 12.9.2 Eli Lilly Business Overview
  • 12.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Eli Lilly Oncology Injection Drug Products Offered
  • 12.9.5 Eli Lilly Recent Development
• 12.10 Praecis Pharmaceuticals
  • 12.10.1 Praecis Pharmaceuticals Corporation Information
  • 12.10.2 Praecis Pharmaceuticals Business Overview
  • 12.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
  • 12.10.5 Praecis Pharmaceuticals Recent Development
• 12.11 Millennium Pharmaceuticals
  • 12.11.1 Millennium Pharmaceuticals Corporation Information
  • 12.11.2 Millennium Pharmaceuticals Business Overview
  • 12.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Millennium Pharmaceuticals Oncology Injection Drug Products Offered
  • 12.11.5 Millennium Pharmaceuticals Recent Development
• 12.12 Debiopharm
  • 12.12.1 Debiopharm Corporation Information
  • 12.12.2 Debiopharm Business Overview
  • 12.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Debiopharm Oncology Injection Drug Products Offered
  • 12.12.5 Debiopharm Recent Development
• 12.13 Alza
  • 12.13.1 Alza Corporation Information
  • 12.13.2 Alza Business Overview
  • 12.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Alza Oncology Injection Drug Products Offered
  • 12.13.5 Alza Recent Development
• 12.14 CordenPharma
  • 12.14.1 CordenPharma Corporation Information
  • 12.14.2 CordenPharma Business Overview
  • 12.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 CordenPharma Oncology Injection Drug Products Offered
  • 12.14.5 CordenPharma Recent Development
• 12.15 Pharmascience
  • 12.15.1 Pharmascience Corporation Information
  • 12.15.2 Pharmascience Business Overview
  • 12.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Pharmascience Oncology Injection Drug Products Offered
  • 12.15.5 Pharmascience Recent Development

13 Oncology Injection Drug Manufacturing Cost Analysis

• 13.1 Oncology Injection Drug Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Oncology Injection Drug
• 13.4 Oncology Injection Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Oncology Injection Drug Distributors List
• 14.3 Oncology Injection Drug Customers

15 Market Dynamics

• 15.1 Oncology Injection Drug Market Trends
• 15.2 Oncology Injection Drug Drivers
• 15.3 Oncology Injection Drug Market Challenges
• 15.4 Oncology Injection Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List